Nonalcoholic steatohepatitis (NASH) cirrhosis: a snapshot of therapeutic agents in clinical development and the optimal design for clinical trials
Sign Up to like & getrecommendations! Published in 2022 at "Expert Opinion on Investigational Drugs"
DOI: 10.1080/13543784.2022.2032640
Abstract: ABSTRACT Introduction Patients with nonalcoholic steatohepatitis (NASH)-associated cirrhosis have the highest rates of major adverse liver outcomes (MALO) within the fatty liver disease spectrum and therefore have the highest unmet need for effective therapeutic agents.… read more here.
Keywords: nash cirrhosis; development; design; cirrhosis ... See more keywords
Inadequate Hepatocellular Carcinoma Screening in Patients With Nonalcoholic Steatohepatitis Cirrhosis
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Clinical Gastroenterology"
DOI: 10.1097/mcg.0000000000001075
Abstract: Background: Nonalcoholic steatohepatitis (NASH) is a common cause of liver disease which can progress to cirrhosis and hepatocellular carcinoma (HCC). American Association for the Study of Liver Diseases (AASLD) guidelines recommend abdominal ultrasound, with or… read more here.
Keywords: nonalcoholic steatohepatitis; nash cirrhosis; surveillance; hcv cirrhosis ... See more keywords
Poor Survival After Retransplantation in NASH Cirrhosis
Sign Up to like & getrecommendations! Published in 2019 at "Transplantation"
DOI: 10.1097/tp.0000000000002135
Abstract: Background Nonalcoholic steatohepatitis (NASH) cirrhosis is a common indication for liver transplantation (LT) in the United States. There is a paucity of data on retransplantation (re-LT) in those who were initially transplanted for NASH. Methods… read more here.
Keywords: poor survival; nash cirrhosis; survival retransplantation; nash group ... See more keywords
Gut Microbiome in the Progression of NAFLD, NASH and Cirrhosis, and Its Connection with Biotics: A Bibliometric Study Using Dimensions Scientific Research Database
Sign Up to like & getrecommendations! Published in 2023 at "Biology"
DOI: 10.3390/biology12050662
Abstract: Simple Summary There is accumulating evidence that gut microbiome dysbiosis is associated with the etiopathogenesis of nonalcoholic fatty liver disease (NAFLD), from the onset of the disease to the progressive stages of nonalcoholic steatohepatitis (NASH)… read more here.
Keywords: nash cirrhosis; progression nafld; cirrhosis; gut microbiome ... See more keywords